Health Observance

Insulin was discovered 100 years ago

But it took a lot more than one scientific breakthrough to get a diabetes treatment to patients
James P. Brody
By James P. Brody
Aug. 15, 2021

Diabetes was a fatal disease before insulin was discovered on July 27, 1921. A century ago, people diagnosed with this metabolic disorder usually survived only a few years. Physicians had no way to treat their diabetic patients’ dangerously high blood sugar levels, which were due to a lack of the hormone insulin. Today, though, nearly 1.6 million Americans are living normal lives with Type 1 diabetes thanks to the discovery of insulin.

This medical breakthrough is usually attributed to one person, Frederick Banting, who was searching for a cure for diabetes. But getting a reliable diabetes treatment depended on the research of two other scientists, Oskar Minkowski and Søren Sørensen, who had done earlier research on seemingly unrelated topics.

I’m a biomedical engineer, and I teach a course on the history of the treatment of diabetes. With my students, I emphasize the importance of unrelated basic research in the development of medical treatments. The story of insulin illustrates the point that medical innovations build on a foundation of basic science and then require skilled engineers to get a treatment out of the lab and to the people who need it.

Insulin_Shock_Therapy_1930-890x622.jpg
Wikimedia Commons
This photo, probably taken in the late 1930s or early 1940s, shows nurses performing insulin shock therapy on a patient. The procedure was first made public in 1933.

Basic research pointed to the pancreas

Diabetes had been known since antiquity. The first symptoms were often a prodigious thirst and urination. Within weeks the patient would be losing weight. Within months, the patient would enter a coma, then die. For centuries, no one had any clue about what caused diabetes.

People had, though, been aware of the pancreas for centuries. The Greek anatomist Herophilos first described it around 300 B.C. Based on its anatomical location, people suspected it was involved in the digestive system. But no one knew whether the pancreas was an essential organ, like the stomach, or extraneous, like the appendix.

Minkowski-445x634.jpg
Wikimedia Commons
Oskar Minkowski discovered the pancreatic origin of diabetes almost by accident.

In 1889, Oskar Minkowski, a pathologist at the University of Strassburg, in what was then Germany, was one of the most talented surgeons of his time. As part of a study, he performed a surgical feat that was thought to be impossible: keeping an animal alive after totally removing its pancreas.

The dog he operated on survived the surgery, but to Minkowski’s surprise, it began exhibiting all the symptoms of diabetes. Minkowski had discovered that removing the pancreas caused diabetes. Today, this is known as an animal model of the disease. Once an animal model of a disease is established, researchers can experiment with different cures in the animal in hopes they’ll find something that will then work in people.

Can you grind up a pancreas and feed it to a diabetic animal to cure or alleviate the symptoms of diabetes? No, that didn’t work. The problem, understood in today’s terms, is that the pancreas has two functions: producing enzymes for the digestive system and producing insulin. Mixed together, the digestive enzymes destroyed the insulin.

Isolating the insulin

In 1920, Fred Banting, a small-town doctor in London, Ontario, had an idea. He thought that he could surgically tie off the ducts between the pancreas and the digestive system in an animal. Wait for a few weeks, while the part of the pancreas that produces those digestive enzymes decays, then remove the pancreas completely. This decayed pancreas, he thought, would contain the insulin, but not the destructive enzymes.

Photograph_of_F-G-_Banting_and_C-H-_Best_with_a_dog_on_the_roof_of_the_Medical_Building-445x619.jpg
Thomas Fisher Rare Book Library/Wikimedia Commons
Charles Best (left) and Frederick Banting with one of the first dogs to be kept alive with insulin.

On July 27, 1921, he concluded this experiment in the laboratory of J.J.R. Macleod at the University of Toronto. Banting, working with a Toronto student named Charles Best, prepared an extract from the atrophied pancreas of a dog. Then he injected the extract into another dog that had induced diabetes, due to the removal of its pancreas. The animal’s diabetes symptoms began to disappear.

Although Banting’s experiment was successful, his method of insulin purification was impractical. J.J.R. Macleod assigned the biochemist James Collip the task of coming up with a practical method of purifying insulin from a pancreas.

Collip developed a method based on alcohol purification. The concept was simple: He’d mash up a fresh pig pancreas, readily available from butcher shops, and mix it into a solution of alcohol and water. Collip slowly increased the percentage of alcohol in the solution. He found that the insulin would stay dissolved in the solution until he reached a critical concentration of alcohol, then it would suddenly fall out of solution, no longer dissolved in the liquid. By collecting that solid precipitate at the bottom of a flask, he had a purified form of insulin.

Collip’s extraction of insulin allowed Banting and others at the University of Toronto Hospital to begin treating patients. The first injections took place in January 1922. Within weeks, the results were miraculous. These injections of insulin helped dozens of patients who were close to dying regain normal activities. Word spread. Demand for insulin increased.

Insight from a brewery

But disaster struck when Collip failed to purify larger batches of insulin. He was puzzled why, following the exact same recipe as he’d used before, his preparations lacked insulin. J.J.R. Macleod now turned to Eli Lilly and Company, a commercial firm in Indiana that made medicinal capsules, for help.

At Eli Lilly, the purification problem fell to George Walden, a 27-year-old chemist. Walden thought of a measure that Danish chemist Søren Sørensen had introduced a dozen years before.

Brew-890x593.jpg
The equipment has changed, but breweries still monitor the pH of their beers. Here, a device used to measure pH sits in buffer solution at a craft brewery.

Sørensen was the director in the early 1900s of the Carlsberg Laboratory, set up by the beer company to advance the science of brewing. He introduced the concept of pH as a way to quantify the acidity of a solution. A higher pH during the brewing stage leads to a more bitter-tasting beer.

When Walden measured the pH of the pancreas solution, he discovered that the acidity was far more important to the solubility of insulin than the alcohol concentration. He set up a purification procedure like Collip’s but based on pH rather than alcohol concentration. Collip’s failure to scale up purification of insulin was probably because he neglected to control the pH of the solution carefully.

This insight allowed for mass production of insulin.

Vanquishing a human disease

By May 1924, diabetes was no longer a fatal disease. Physician Joseph Collins, writing in The New York Times, described it this way: “One by one the implacable enemies of man, the diseases which seek his destruction, are overcome by Science. Diabetes, one of the most dreaded, is the latest to succumb.”

Today, the implacable enemies of man include cancer, Alzheimer’s disease and schizophrenia. The cures for each will likely be built from advances made by basic research.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

The Conversation

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
James P. Brody
James P. Brody

James P. Brody has been a professor of biomedical engineering at the University of California, Irvine for over 20 years. His research involves applying computational tools to large data sets to better predict who will develop different forms of cancer. He teaches a popular course on engineering innovations in the treatment of diabetes.

Related articles

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.